|
DK2129693T3
(en)
*
|
2007-03-23 |
2017-02-13 |
Wyeth Llc |
BRIEF PURIFICATION PROCEDURE FOR THE PREPARATION OF STREPTOCOCCUS PNEUMONIAE-Capsule POLYACCHARIDES
|
|
GB0818453D0
(en)
*
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
|
CN102264444B
(zh)
|
2008-10-27 |
2015-08-05 |
诺华股份有限公司 |
纯化方法
|
|
DK2379734T3
(en)
*
|
2008-12-18 |
2018-04-23 |
Wyeth Llc |
Method for Controlling the Molecular Weight of Polysaccharide of Streptococcus Pneumoniae Serotype 19A
|
|
ES2749952T3
(es)
*
|
2008-12-18 |
2020-03-24 |
Wyeth Llc |
Procedimiento de control del peso molecular de polisacáridos de Streptococcus pneumoniae usando carbono
|
|
WO2010125480A1
(en)
|
2009-04-30 |
2010-11-04 |
Coley Pharmaceutical Group, Inc. |
Pneumococcal vaccine and uses thereof
|
|
CN102481352A
(zh)
|
2009-06-22 |
2012-05-30 |
惠氏有限责任公司 |
金黄色葡萄球菌抗原的免疫原性组合物
|
|
SA114350400B1
(ar)
|
2009-06-22 |
2016-05-26 |
ويث ال ال سي |
تركيبات وطرق لتحضير تركيبات مولدة للمناعة لمقترن بولي سكاريد كبسولي للنمط المصلي 5 و 8 من المكورات العنقودية الذهبية
|
|
TW201136603A
(en)
*
|
2010-02-09 |
2011-11-01 |
Merck Sharp & Amp Dohme Corp |
15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
|
|
US8841104B2
(en)
|
2010-04-21 |
2014-09-23 |
Nanomr, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
|
US20110262989A1
(en)
|
2010-04-21 |
2011-10-27 |
Nanomr, Inc. |
Isolating a target analyte from a body fluid
|
|
US9476812B2
(en)
|
2010-04-21 |
2016-10-25 |
Dna Electronics, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
|
WO2011145108A2
(en)
*
|
2010-05-15 |
2011-11-24 |
Serum Institute Of India Ltd. |
Purification of capsular polysaccharides
|
|
JP5944480B2
(ja)
*
|
2011-03-22 |
2016-07-05 |
セルム・インスティテュート・オブ・インディア・ピーブイティー．・リミテッド |
多糖を調製するための新規な方法
|
|
CN102660601B
(zh)
*
|
2012-04-17 |
2015-10-28 |
江苏康泰生物医学技术有限公司 |
快速纯化细菌荚膜多糖的方法
|
|
CN102660603B
(zh)
*
|
2012-04-17 |
2015-03-25 |
江苏康泰生物医学技术有限公司 |
一种快速纯化细菌荚膜多糖的方法
|
|
CN102660602B
(zh)
*
|
2012-04-17 |
2015-03-25 |
江苏康泰生物医学技术有限公司 |
快速纯化细菌荚膜多糖的方法
|
|
US9650411B2
(en)
*
|
2012-08-07 |
2017-05-16 |
Kyowa Hakko Kirin Co., Ltd. |
Method of purifying protein
|
|
MX363051B
(es)
|
2012-09-07 |
2019-03-06 |
Sk Bioscience Co Ltd |
Metodo para producir un polisacárido capsular con un serotipo de neumococo.
|
|
AR092896A1
(es)
|
2012-10-03 |
2015-05-06 |
Novartis Ag |
Composiciones inmunogenicas
|
|
US9804069B2
(en)
|
2012-12-19 |
2017-10-31 |
Dnae Group Holdings Limited |
Methods for degrading nucleic acid
|
|
US10000557B2
(en)
|
2012-12-19 |
2018-06-19 |
Dnae Group Holdings Limited |
Methods for raising antibodies
|
|
US9599610B2
(en)
|
2012-12-19 |
2017-03-21 |
Dnae Group Holdings Limited |
Target capture system
|
|
US9434940B2
(en)
|
2012-12-19 |
2016-09-06 |
Dna Electronics, Inc. |
Methods for universal target capture
|
|
US9551704B2
(en)
|
2012-12-19 |
2017-01-24 |
Dna Electronics, Inc. |
Target detection
|
|
US9995742B2
(en)
|
2012-12-19 |
2018-06-12 |
Dnae Group Holdings Limited |
Sample entry
|
|
WO2015005961A1
(en)
|
2013-07-12 |
2015-01-15 |
Emd Millipore Corporation |
A method of determining virus removal from a sample containing a target protein using activated carbon
|
|
WO2015095868A1
(en)
|
2013-12-20 |
2015-06-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
|
PT3096785T
(pt)
|
2014-01-21 |
2020-10-13 |
Pfizer |
Composições imunogénicas que compreendem antigénios de sacáridos capsulares conjugados e utilizações das mesmas
|
|
US11160855B2
(en)
|
2014-01-21 |
2021-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
SI3096783T1
(sl)
|
2014-01-21 |
2021-09-30 |
Pfizer Inc. |
Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati
|
|
KR20210032013A
(ko)
|
2014-01-21 |
2021-03-23 |
화이자 인코포레이티드 |
스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 및 그의 접합체
|
|
US9815886B2
(en)
|
2014-10-28 |
2017-11-14 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
|
EP3244917B1
(en)
|
2015-01-15 |
2023-04-19 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
TWI807252B
(zh)
|
2015-05-04 |
2023-07-01 |
美商輝瑞股份有限公司 |
Ｂ型鏈球菌多醣-蛋白質軛合物、製造軛合物之方法、含軛合物之免疫原性組成物、及其用途
|
|
WO2016204265A1
(ja)
*
|
2015-06-18 |
2016-12-22 |
一般財団法人阪大微生物病研究会 |
肺炎球菌補体依存性殺菌能測定方法
|
|
KR102225282B1
(ko)
|
2015-07-21 |
2021-03-10 |
화이자 인코포레이티드 |
접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
|
|
CN105131139B
(zh)
*
|
2015-07-31 |
2018-02-13 |
兰州生物制品研究所有限责任公司 |
一种肺炎链球菌荚膜多糖的纯化方法
|
|
CA3005524C
(en)
|
2015-11-20 |
2023-10-10 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
TWI770044B
(zh)
|
2016-08-05 |
2022-07-11 |
南韓商Ｓｋ生物科技股份有限公司 |
多價肺炎球菌多醣-蛋白質共軛物組成物(一)
|
|
SG11201900794PA
(en)
|
2016-08-05 |
2019-02-27 |
Sanofi Pasteur Inc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
|
MX2019007910A
(es)
|
2016-12-30 |
2019-12-05 |
Sutrovax Inc |
Conjugados de polipeptido-antigeno con aminoacidos no naturales.
|
|
MX392525B
(es)
|
2017-01-20 |
2025-03-12 |
Pfizer |
Composiciones inmunogenicas para su uso en vacunas neumococicas
|
|
KR20240169144A
(ko)
|
2017-01-31 |
2024-12-02 |
머크 샤프 앤드 돔 엘엘씨 |
다당류-단백질 접합체 제조 방법
|
|
US20200222550A1
(en)
|
2017-01-31 |
2020-07-16 |
Merck Sharp & Dohme Corp. |
Methods for production of capsular polysaccharide protein conjugates from streptococcus pneumoniae serotype 19f
|
|
KR102701633B1
(ko)
|
2017-02-24 |
2024-09-02 |
머크 샤프 앤드 돔 엘엘씨 |
폐렴구균 접합체 백신 제제
|
|
KR20190121330A
(ko)
|
2017-02-24 |
2019-10-25 |
머크 샤프 앤드 돔 코포레이션 |
스트렙토코쿠스 뉴모니아에 폴리사카라이드-단백질 접합체의 면역원성의 증진
|
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
|
KR20240018698A
(ko)
|
2017-06-10 |
2024-02-13 |
인벤트프라이즈 인크. |
면역원성과 항원항체 결합성이 개선된 2가 또는 다가 접합체 다당류를 가진 다가 접합체 백신
|
|
US10729763B2
(en)
|
2017-06-10 |
2020-08-04 |
Inventprise, Llc |
Mixtures of polysaccharide-protein pegylated compounds
|
|
US10435433B2
(en)
|
2017-07-05 |
2019-10-08 |
Inventprise, Llc |
Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
|
|
US10702596B2
(en)
|
2017-07-05 |
2020-07-07 |
Inventprise, Llc |
Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
|
|
WO2019050813A1
(en)
|
2017-09-07 |
2019-03-14 |
Merck Sharp & Dohme Corp. |
ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER
|
|
BR112020004509A8
(pt)
|
2017-09-07 |
2023-01-31 |
Merck Sharp & Dohme |
Conjugado polissacarídeo-proteína carreadora, composição imunogênica compreendendo o mesmo e uso do referido conjugado
|
|
US11389540B2
(en)
|
2017-09-07 |
2022-07-19 |
Merck Sharp & Dohme Llc |
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
|
|
CN107936128B
(zh)
*
|
2017-11-22 |
2020-07-03 |
成都欧林生物科技股份有限公司 |
一种简便有效的细菌疫苗纯化方法
|
|
BR112020011414B8
(pt)
|
2017-12-06 |
2023-01-31 |
Merck Sharp & Dohme |
Composições imunogênicas multivalentes compreendendo conjugados de proteína carreadora e polissacarídeo de s. pneumoniae
|
|
BR112020014978A2
(pt)
|
2018-02-05 |
2020-12-22 |
Sanofi Pasteur, Inc. |
Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
|
|
KR20230008923A
(ko)
|
2018-02-05 |
2023-01-16 |
사노피 파스퇴르 인코포레이티드 |
다가 폐렴구균성 다당류-단백질 접합체 조성물
|
|
US12144855B2
(en)
|
2018-04-30 |
2024-11-19 |
Merck Sharp & Dohme Llc |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
|
|
JP7397000B2
(ja)
|
2018-04-30 |
2023-12-12 |
メルク・シャープ・アンド・ドーム・エルエルシー |
凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法
|
|
US20210252125A1
(en)
|
2018-04-30 |
2021-08-19 |
Merck Sharp & Dohme Corp. |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
|
|
DK3817775T3
(da)
|
2018-07-04 |
2024-09-16 |
Vaxcyte Inc |
Forbedringer i immunogene konjugater
|
|
WO2020010016A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Self-adjuvanted immunogenic conjugates
|
|
WO2020010000A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Improved methods for the preparation of immunogenic conjugates
|
|
US12018134B2
(en)
*
|
2018-07-19 |
2024-06-25 |
Glaxosmithkline Biological Sa |
Processes for preparing dried polysaccharides
|
|
JP7585203B2
(ja)
|
2018-12-12 |
2024-11-18 |
ファイザー・インク |
免疫原性多重ヘテロ抗原多糖－タンパク質コンジュゲートおよびその使用
|
|
EP3897705A2
(en)
|
2018-12-19 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
|
JP7239509B6
(ja)
*
|
2019-02-22 |
2023-03-28 |
ファイザー・インク |
細菌多糖類を精製するための方法
|
|
CA3136278A1
(en)
|
2019-04-10 |
2020-10-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
|
PH12022550110A1
(en)
|
2019-07-31 |
2022-12-12 |
Sk Bioscience Co Ltd |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
|
US12473379B2
(en)
*
|
2019-09-06 |
2025-11-18 |
Serum Institute Of India Private Limited |
Method for obtaining purified bacterial polysaccharides
|
|
MX2022010355A
(es)
|
2020-02-21 |
2022-09-21 |
Pfizer |
Purificacion de sacaridos.
|
|
KR20230022867A
(ko)
*
|
2020-06-12 |
2023-02-16 |
바스프 에스이 |
발효 브로스의 개선된 탈염 및 올리고당과 같은 정밀 화학물질의 정제
|
|
EP4192499A4
(en)
|
2020-08-10 |
2024-09-25 |
Inventprise, Inc. |
Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
|
|
CA3192786A1
(en)
|
2020-08-26 |
2022-03-03 |
Pfizer Inc. |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
|
GB202016165D0
(en)
|
2020-10-12 |
2020-11-25 |
Optivalent Ltd |
Vaccine
|
|
EP4232593A1
(en)
|
2020-10-22 |
2023-08-30 |
Pfizer Inc. |
Methods for purifying bacterial polysaccharides
|
|
CA3200602A1
(en)
|
2020-11-04 |
2022-05-12 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
US20230405137A1
(en)
|
2020-11-10 |
2023-12-21 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
TW202245835A
(zh)
|
2021-02-04 |
2022-12-01 |
美商默沙東有限責任公司 |
用於肺炎球菌結合物疫苗之奈米乳化液佐劑組合物
|
|
WO2022234416A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
WO2022234405A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against bacterial and betacoronavirus infections
|
|
KR20230175284A
(ko)
|
2021-05-28 |
2023-12-29 |
화이자 인코포레이티드 |
접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도
|
|
CA3221075A1
(en)
|
2021-05-28 |
2022-12-01 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2023135515A1
(en)
|
2022-01-13 |
2023-07-20 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
GB2614916A
(en)
|
2022-01-25 |
2023-07-26 |
Optivalent Ltd |
Intradermal vaccine complement
|
|
US20250163484A1
(en)
|
2022-02-25 |
2025-05-22 |
Pfizer Inc. |
Methods for Incorporating Azido Groups in Bacterial Capsular Polysaccharides
|
|
WO2024084397A1
(en)
|
2022-10-19 |
2024-04-25 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
WO2024110827A1
(en)
|
2022-11-21 |
2024-05-30 |
Pfizer Inc. |
Methods for preparing conjugated capsular saccharide antigens and uses thereof
|
|
IL321062A
(en)
|
2022-11-22 |
2025-07-01 |
Pfizer |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
KR20250113501A
(ko)
|
2022-12-01 |
2025-07-25 |
화이자 인코포레이티드 |
폐렴구균 접합체 백신 제형
|
|
WO2024166008A1
(en)
|
2023-02-10 |
2024-08-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
CN121038808A
(zh)
|
2023-03-30 |
2025-11-28 |
辉瑞公司 |
包含缀合的荚膜糖抗原的免疫原性组合物及其用途
|
|
PE20252779A1
(es)
|
2023-04-14 |
2025-12-22 |
Pfizer |
Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y usos de estos
|
|
WO2024224266A1
(en)
|
2023-04-24 |
2024-10-31 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
GEAP202616883A
(en)
|
2023-05-18 |
2026-03-25 |
Merck Sharp & Dohme Llc |
Compounds and adjuvant formulations useful in pneumococcal vaccines
|
|
EP4713008A2
(en)
|
2023-05-19 |
2026-03-25 |
GlaxoSmithKline Biologicals S.A. |
Methods for eliciting an immune response to respiratory syncycial virus and streptococcus pneumoniae infection
|
|
TW202527906A
(zh)
|
2023-09-14 |
2025-07-16 |
美商輝瑞股份有限公司 |
包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途
|
|
WO2025133971A1
(en)
|
2023-12-23 |
2025-06-26 |
Pfizer Inc. |
Improved methods for producing bacterial capsular saccharide glycoconjugates
|
|
WO2025186705A2
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2025219904A1
(en)
|
2024-04-19 |
2025-10-23 |
Pfizer Inc. |
Improved methods for producing glycoconjugates by reductive amination in aprotic solvent
|
|
WO2025219908A2
(en)
|
2024-04-19 |
2025-10-23 |
Pfizer Inc. |
Media and fermentation methods for polysaccharide production in bacterial cell culture
|
